Patents by Inventor Edward Routledge

Edward Routledge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized anti-CD3 specific antibodies
    Publication number: 20070178092
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: December 11, 2006
    Publication date: August 2, 2007
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Publication number: 20070154477
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: February 12, 2007
    Publication date: July 5, 2007
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Publication number: 20070134241
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: January 31, 2007
    Publication date: June 14, 2007
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Publication number: 20060269547
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: August 10, 2006
    Publication date: November 30, 2006
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Publication number: 20060165692
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 27, 2006
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Publication number: 20060165691
    Abstract: Novel aglycosylated antibodies having a binding affinity for the Cd3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 27, 2006
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Publication number: 20060165693
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 27, 2006
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Publication number: 20060088526
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: December 15, 2005
    Publication date: April 27, 2006
    Applicant: BTG International Limited
    Inventors: Sarah Bolt, Michael Clark, Scott Gorman, Edward Routledge, Herman Waldman